AMRX PDUFA decision: a positive outcome, +1.3%

On October 23, 2019, Amneal Pharmaceuticals, Inc. reached its PDUFA decision. The result was a positive outcome, and the stock moved +1.3% in the window around the event. It had already run -14.5% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.